metricas
covid
Buscar en
Acta Otorrinolaringológica Española
Toda la web
Inicio Acta Otorrinolaringológica Española Nasal Leprosy: Impact of Multitherapy in the Morphology and Physiology of the No...
Journal Information
Vol. 58. Issue 5.
Pages 182-186 (January 2007)
Share
Share
Download PDF
More article options
Vol. 58. Issue 5.
Pages 182-186 (January 2007)
Nasal Leprosy: Impact of Multitherapy in the Morphology and Physiology of the Nose
Lepra nasal: impacto de la multiterapia en la morfología y la fisiología nasal
Visits
573
María Teresa Torres-Larrosaa,
Corresponding author
matetorres@eresmas.com

Correspondence: San Juan Bautista, 16, 1.° A. 38002 Santa Cruz de Tenerife. Tenerife. Islas Canarias. España.
, Luis Jorge Pérez-Péreza, María Vicenta Quintana Ginestarb, Vicente Torres-Perisc, Juan José Artazkoz del Toroa
a Servicio de Otorrinolaringología, Hospital Universitario Nuestra Señora de Candelaria, Tenerife, Spain
b Sanatorio San Francisco de Borja, Fontilles, Alicante, Spain
c Servicio de Dermatología, Hospital Clínico Universitario de Valencia, Valencia, Spain
This item has received
Article information
Introduction

The multi-drug therapy protocol has allowed leprosy patients following this strategy to achieve complete recovery without developing neurotrophic sequelae or deformities.

Objectives To assess the impact of multi-drug therapy on the development of nasal deformities and nasal airway patency.

Patients and method

In an overall group of 84 patients studied, 38 were treated with a therapy based on a single drug and 22 were treated with multi-drug while 24 subjects formed a control group. Nose morphology was determined by anterior rhinoscopy. Nasal patency and flow resistances were measured by anterior rhinomanometry. The results were compared by using the Anova test for a single variable.

Results

The nasal structures in the group with therapy based on a single drug underwent resorption of bone and cartilage in the structures of the nose and increased flow resistance. In the group receiving the multi-drug protocol, there were no significant morphological alterations and nasal patency and flow resistance remained within normal levels.

Conclusions

The multi-drug therapy is effective in preventing the development of nasal deformities and maintains normal nasal airflow.

Key words:
Nose deformities
Rhinomanometry
Leprosy
Multiple leprostatic agents
Introducción

El protocolo de terapia combinada ha permitido que los enfermos de lepra tratados según esta estrategia alcancen una curación sin secuelas neurotróficas ni deformidades.

Objetivos

Determinar el impacto de la multiterapia en el desarrollo de las alteraciones del esqueleto óseo cartilaginoso y en la función respiratoria nasal.

Pacientes y método

Estudiamos a 84 sujetos: 38 pacientes tratados con monoterapia, 22 pacientes tratados con multiterapia y 24 sujetos control. Exploramos la morfología nasal mediante rinoscopia anterior y la función respiratoria nasal mediante rinomanometría anterior activa. En el análisis estadístico se ha utilizado el test ANOVA de un factor.

Resultados

En el grupo de monoterapia observamos una reabsorción osteocartilaginosa de las estructuras nasales y un aumento de las resistencias nasales. Los pacientes que recibieron multiterapia no presentaron cambios morfológicos significativos y la función respiratoria nasal se mantuvo dentro de la normalidad.

Conclusiones

La terapia combinada es eficaz porque previene la aparición de deformidades nasales y la insuficiencia respiratoria nasal.

Palabras clave:
Deformidades nasales
Rinomanometría
Lepra
Multiterapia

Article

These are the options to access the full texts of the publication Acta Otorrinolaringológica Española
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Acta Otorrinolaringológica Española

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos